Exclusive special offer and discount title banner vector image

UNITED STATES PHARMACEUTICAL LOGISTICS MARKET FORECAST 2024-2032

SCOPE OF THE REPORT

United States Pharmaceutical Logistics Market by Product (Branded Drugs, Generic Drugs, OTC) Market by Therapy Area (Communicable Diseases, Oncology, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Neurological Disorders, Pain Management, Respiratory Diseases, Other Therapy Areas) Market by Type (Non-cold Chain Logistics, Cold Chain Logistics) Market by Component (Storage, Transportation, Monitoring Components)

REQUEST CUSTOMIZATION

MARKET OVERVIEW

The United States pharmaceutical logistics market is anticipated to progress at a CAGR of 7.62% over the forecast period of 2024-2032. It is positioned to reach a revenue of $52468.91 million by 2032. 

The United States pharmaceutical logistics market is a dynamic and critical component of the healthcare sector, serving the intricate needs of transporting pharmaceutical products across the country. The market is driven by extensive demand for a wide range of medications, including prescription drugs, vaccines, and medical devices. It caters to the healthcare needs of a vast and diverse population.

One of the key factors shaping this market is the stringent regulatory environment governing pharmaceutical transportation and storage. Compliance with regulations such as Good Distribution Practice (GDP) guidelines is paramount, ensuring the safety, efficacy, and integrity of pharmaceutical products throughout the supply chain. Companies in this market must invest in robust logistics infrastructure and adhere to strict quality standards to maintain regulatory compliance.

United States Pharmaceutical Logistics Market

To Know More About This Report, Request a Free Sample Copy

Technological advancements play a pivotal role in enhancing efficiency and transparency within the pharmaceutical logistics market in the United States. Innovations such as cold chain logistics and temperature-controlled storage solutions are revolutionizing how pharmaceutical products are handled, monitored, and traced. Additionally, real-time tracking systems and blockchain technology play crucial roles in ensuring the seamless journey of these products from manufacturers to end-users.

Moreover, the COVID-19 pandemic has underlined the importance of resilient and agile pharmaceutical logistics networks. The rapid distribution of vaccines and critical healthcare supplies during the pandemic highlighted the necessity for reliable and scalable logistics solutions. The healthcare sphere continues to evolve with advancements in biotechnology and personalized medicine. Consequently, the United States pharmaceutical logistics market is poised for further growth and innovation to meet the evolving needs of the healthcare industry.

The United States pharmaceutical logistics market segmentation includes the market by product, therapy area, type, and component. The product segment is further divided into branded drugs, generic drugs, and OTC. Branded drugs refer to medications developed and marketed by pharmaceutical companies under a specific brand name, often protected by patents. These drugs are typically more expensive and are known for their specific formulations and therapeutic effects.

On the other hand, generic drugs are pharmaceutical products that are bioequivalent to branded drugs in terms of dosage form, strength, safety, efficacy, route of administration, quality, and intended use. However, generic drugs are usually marketed under their chemical or generic name without a brand name, making them more affordable alternatives to branded medications.

The over-the-counter (OTC) sub-segment includes medications that can be purchased directly by consumers without a prescription. These products are typically used for common health issues such as colds, allergies, pain relief, and digestive problems. Government agencies regulate OTC drugs to ensure their safety and effectiveness for consumer use.

Each sub-segment within the United States pharmaceutical logistics market plays a significant role in meeting the population’s healthcare needs. The logistics and supply chain management for these products require specialized handling, storage, transportation, and distribution. This ensures their integrity, safety, and timely delivery to healthcare providers, pharmacies, and ultimately to end-users across the country.

Some of the leading players in the United States pharmaceutical logistics market include DB Schenker, Deutsche Post AG, DSV, FedEx, Kuehne + Nagel, etc. 

FedEx is a US-based company offering a wide range of services, including e-commerce, transportation, and business services. FedEx operates through six segments: FedEx Express for domestic and international shipping, FedEx Ground for small package delivery in North America, FedEx Freight for LTL freight services, and FedEx Services for various business support. Additionally, it has a FedEx Office for printing and shipping and FedEx Logistics for specialized solutions worldwide.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2024-2032
Base Year2023
Market Historical Years2018-2022
Forecast Units

Revenue ($ Million)

Segments Analyzed
Product, Therapy Area, Type, and Component
Countries AnalyzedUnited States
Companies AnalyzedAgility Logistics, AP Moller – Maersk, Cardinal Health, Cencora (AmerisourceBergen), CEVA Logistics, DB Schenker, Deutsche Post AG, DSV, FedEx, Kuehne + Nagel
TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. COUNTRY SNAPSHOT
    3. COUNTRY ANALYSIS 
    4. SCOPE OF STUDY
    5. CRISIS SCENARIO ANALYSIS
    6. MAJOR MARKET FINDINGS
      1. BRANDED DRUGS ARE THE MOST COMMONLY USED PRODUCTS IN THE PHARMACEUTICAL LOGISTICS MARKET
      2. COMMUNICABLE DISEASES HOLD THE LARGEST MARKET SHARE IN THE THERAPY AREA
      3. COLD CHAIN LOGISTICS IS THE FASTEST-GROWING TYPE WITHIN THE PHARMACEUTICAL LOGISTICS MARKET
      4. MONITORING OF PHARMACEUTICAL LOGISTICS OPERATIONS IS INCREASINGLY BECOMING A FOCUS AREA
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. RISING NEED FOR TEMPERATURE-CONTROLLED SOLUTIONS IN PHARMACEUTICALS
      2. EXPANSION OF OCEAN FREIGHT SERVICES IN PHARMACEUTICAL INDUSTRY
      3. RISE IN CONSUMER PREFERENCE FOR OVER-THE-COUNTER MEDICINES
      4. SURGE IN PHARMACEUTICAL LOGISTICS DURING THE UNITED STATES COVID-19 PANDEMIC
    2. KEY RESTRAINTS
      1. RIGOROUS REGULATORY REQUIREMENTS IN PHARMACEUTICAL LOGISTICS
      2. ENSURING REAL-TIME TRANSPARENCY AND RELIABILITY IN PHARMACEUTICAL LOGISTICS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
      1. SURGE IN DEMAND FOR CELL & GENE THERAPY LOGISTICS
      2. REVOLUTIONIZING PHARMACEUTICAL LOGISTICS THROUGH DIGITAL TRANSFORMATION
      3. INCREASING CLINICAL TRIALS LOGISTICS DEMANDS
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING FOR UNITED STATES
    4. MARKET CONCENTRATION ANALYSIS
    5. VALUE CHAIN ANALYSIS
      1. MANUFACTURING
      2. STORAGE
      3. TRANSPORTATION
      4. DISTRIBUTION
      5. MONITORING COMPONENTS
      6. CONSUMPTION
    6. KEY BUYING CRITERIA
      1. TYPE OF LOGISTICS
      2. SERVICES OFFERED
      3. MODE OF TRANSPORTATION
      4. APPLICATION
      5. REGULATORY COMPLIANCE
      6. TECHNOLOGICAL CAPABILITIES
      7. COST
      8. RELIABILITY
      9. AGILITY
  5. MARKET BY PRODUCT
    1. BRANDED DRUGS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. GENERIC DRUGS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. OTC
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  6. MARKET BY THERAPY AREA
    1. COMMUNICABLE DISEASES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. ONCOLOGY
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. DIABETES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    4. CARDIOVASCULAR DISEASES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    5. AUTOIMMUNE DISEASES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    6. NEUROLOGICAL DISORDERS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    7. PAIN MANAGEMENT
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    8. RESPIRATORY DISEASES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    9. OTHER THERAPY AREAS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  7. MARKET BY TYPE
    1. NON-COLD CHAIN LOGISTICS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. COLD CHAIN LOGISTICS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  8. MARKET BY COMPONENT
    1. STORAGE
      1. WAREHOUSE
        1. MARKET FORECAST FIGURE
        2. SEGMENT ANALYSIS
      2. REFRIGERATED CONTAINERS
        1. MARKET FORECAST FIGURE
        2. SEGMENT ANALYSIS
    2. TRANSPORTATION
      1. OVERLAND LOGISTICS
        1. MARKET FORECAST FIGURE
        2. SEGMENT ANALYSIS
      2. SEA FREIGHT LOGISTICS
        1. MARKET FORECAST FIGURE
        2. SEGMENT ANALYSIS
      3. AIR FREIGHT LOGISTICS
        1. MARKET FORECAST FIGURE
        2. SEGMENT ANALYSIS
    3. MONITORING COMPONENTS
      1. HARDWARE
        1. SENSORS
          1. MARKET FORECAST FIGURE
          2. SEGMENT ANALYSIS
        2. RFID DEVICES
          1. MARKET FORECAST FIGURE
          2. SEGMENT ANALYSIS
        3. TELEMATICS
          1. MARKET FORECAST FIGURE
          2. SEGMENT ANALYSIS
        4. NETWORKING DEVICES
          1. MARKET FORECAST FIGURE
          2. SEGMENT ANALYSIS
      2. SOFTWARE
        1. MARKET FORECAST FIGURE
        2. SEGMENT ANALYSIS
  9. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. AGILITY LOGISTICS
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      2. AP MOLLER – MAERSK
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      3. CARDINAL HEALTH
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      4. CENCORA (AMERISOURCEBERGEN)
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      5. CEVA LOGISTICS
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      6. DB SCHENKER
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      7. DEUTSCHE POST AG
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      8. DSV
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      9. FEDEX
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES
      10. KUEHNE + NAGEL
        1. COMPANY OVERVIEW
        2. PRODUCT PORTFOLIO
        3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – PHARMACEUTICAL LOGISTICS

TABLE 2: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 4: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 6: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 8: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 10: UNITED STATES STORAGE MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 11: UNITED STATES STORAGE MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 12: UNITED STATES TRANSPORTATION MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 13: UNITED STATES TRANSPORTATION MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 14: UNITED STATES MONITORING COMPONENTS MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 15: UNITED STATES MONITORING COMPONENTS MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 16: UNITED STATES HARDWARE MARKET, BY HARDWARE TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 17: UNITED STATES HARDWARE MARKET, BY HARDWARE TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 18: LIST OF MERGERS & ACQUISITIONS

TABLE 19: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 20: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 21: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES

FIGURE 4: MARKET CONCENTRATION ANALYSIS

FIGURE 5: VALUE CHAIN ANALYSIS

FIGURE 6: KEY BUYING CRITERIA

FIGURE 7: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023

FIGURE 8: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY BRANDED DRUGS, 2024-2032 (IN $ MILLION)

FIGURE 9: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY GENERIC DRUGS, 2024-2032 (IN $ MILLION)

FIGURE 10: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY OTC, 2024-2032 (IN $ MILLION)

FIGURE 11: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY THERAPY AREA, IN 2023

FIGURE 12: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY COMMUNICABLE DISEASES, 2024-2032 (IN $ MILLION)

FIGURE 13: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 14: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY DIABETES, 2024-2032 (IN $ MILLION)

FIGURE 15: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY CARDIOVASCULAR DISEASES, 2024-2032 (IN $ MILLION)

FIGURE 16: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY AUTOIMMUNE DISEASES, 2024-2032 (IN $ MILLION)

FIGURE 17: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY NEUROLOGICAL DISORDERS, 2024-2032 (IN $ MILLION)

FIGURE 18: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY PAIN MANAGEMENT, 2024-2032 (IN $ MILLION)

FIGURE 19: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY RESPIRATORY DISEASES, 2024-2032 (IN $ MILLION)

FIGURE 20: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY OTHER THERAPY AREAS, 2024-2032 (IN $ MILLION)

FIGURE 21: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2023

FIGURE 22: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY NON-COLD CHAIN LOGISTICS, 2024-2032 (IN $ MILLION)

FIGURE 23: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY COLD CHAIN LOGISTICS, 2024-2032 (IN $ MILLION)

FIGURE 24: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2023

FIGURE 25: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY STORAGE, 2024-2032 (IN $ MILLION)

FIGURE 26: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY WAREHOUSE, 2024-2032 (IN $ MILLION)

FIGURE 27: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY REFRIGERATED CONTAINERS, 2024-2032 (IN $ MILLION)

FIGURE 28: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY TRANSPORTATION, 2024-2032 (IN $ MILLION)

FIGURE 29: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY OVERLAND LOGISTICS, 2024-2032 (IN $ MILLION)

FIGURE 30: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY SEA FREIGHT LOGISTICS, 2024-2032 (IN $ MILLION)

FIGURE 31: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY AIR FREIGHT LOGISTICS, 2024-2032 (IN $ MILLION)

FIGURE 32: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY MONITORING COMPONENTS, 2024-2032 (IN $ MILLION)

FIGURE 33: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY HARDWARE, 2024-2032 (IN $ MILLION)

FIGURE 34: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY SENSORS, 2024-2032 (IN $ MILLION)

FIGURE 35: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY RFID DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 36: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY TELEMATICS, 2024-2032 (IN $ MILLION)

FIGURE 37: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY NETWORKING DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 38: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY SOFTWARE, 2024-2032 (IN $ MILLION)

FAQ’s

Request Customization
Request Customization
Request Free Sample